Ecolab Inc. (ECL) 10-Year Financial Performance & Capital Metrics

ECL • • Industrial / General

Basic MaterialsSpecialty ChemicalsWater Treatment & Environmental ChemicalsWater Treatment Chemicals

AboutEcolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, refining, and petrochemical industries. The Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in Saint Paul, Minnesota.Show more

Revenue $15.74B +2.7%
EBITDA $3.55B +15.0%
Net Income $2.11B +53.9%
EPS (Diluted) 7.37 +53.9%
Gross Margin 43.47% +7.8%
EBITDA Margin 22.54% +12.0%
Operating Margin 16.6% +17.7%
Net Margin 13.42% +49.8%
ROE 25.06% +40.0%
ROIC 12.36% +20.4%
Debt/Equity 0.94 -12.9%
Interest Coverage 7.72 +26.7%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓11 consecutive years of dividend growth
✓High quality earnings: Operating CF exceeds net income
✓Good 3Y average ROE of 19.3%
✓Trading near 52-week high

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y0.98%

5Y4.62%

3Y7.33%

TTM1.38%

Profit (Net Income) CAGR

10Y5.79%

5Y6.27%

3Y23.19%

TTM-2.94%

EPS CAGR

10Y6.49%

5Y6.7%

3Y23.53%

TTM-2.38%

ROCE

10Y Avg12.2%

5Y Avg11.47%

3Y Avg12.18%

Latest14.89%

Peer Comparison

Water Treatment Chemicals

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
HWKNHawkins, Inc.	3.2B	153.19	38.01	6.01%	7.95%	16.4%	2.19%	0.35
ECLEcolab Inc.	78.66B	277.73	37.68	2.75%	12.49%	20.35%	2.31%	0.94
FSIFlexible Solutions International, Inc.	74.25M	5.85	24.38	-0.23%	12.18%	10.93%	0.81%	0.26

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	13.55B	13.15B	13.84B	14.67B	12.56B	11.79B	12.73B	14.19B	15.32B	15.74B
Revenue Growth %	-0.05%	-0.03%	0.05%	0.06%	-0.14%	-0.06%	0.08%	0.11%	0.08%	0.03%
Cost of Goods Sold+	7.18B	6.85B	8.01B	8.61B	7.03B	6.89B	7.51B	8.77B	9.14B	8.9B
COGS % of Revenue	0.53%	0.52%	0.58%	0.59%	0.56%	0.58%	0.59%	0.62%	0.6%	0.57%
Gross Profit+	6.37B	6.3B	5.83B	6.06B	5.53B	4.9B	5.22B	5.42B	6.18B	6.84B
Gross Margin %	0.47%	0.48%	0.42%	0.41%	0.44%	0.42%	0.41%	0.38%	0.4%	0.43%
Gross Profit Growth %	-0.04%	-0.01%	-0.08%	0.04%	-0.09%	-0.11%	0.07%	0.04%	0.14%	0.11%
Operating Expenses+	4.38B	4.3B	3.63B	4.08B	3.62B	3.19B	3.54B	3.81B	4.02B	4.23B
OpEx % of Revenue	0.32%	0.33%	0.26%	0.28%	0.29%	0.27%	0.28%	0.27%	0.26%	0.27%
Selling, General & Admin	4.19B	4.11B	3.43B	3.86B	3.43B	3B	3.35B	3.62B	3.82B	4.02B
SG&A % of Revenue	0.31%	0.31%	0.25%	0.26%	0.27%	0.25%	0.26%	0.26%	0.25%	0.26%
Research & Development	191M	189M	201M	216M	190M	185M	186M	190M	192M	207M
R&D % of Revenue	0.01%	0.01%	0.01%	0.01%	0.02%	0.02%	0.01%	0.01%	0.01%	0.01%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	1.98B	2.01B	2.2B	1.98B	1.91B	1.71B	1.68B	1.61B	2.16B	2.61B
Operating Margin %	0.15%	0.15%	0.16%	0.14%	0.15%	0.15%	0.13%	0.11%	0.14%	0.17%
Operating Income Growth %	-0.02%	0.01%	0.1%	-0.1%	-0.04%	-0.1%	-0.01%	-0.04%	0.34%	0.21%
EBITDA+	2.84B	2.86B	3.09B	2.92B	2.68B	2.52B	2.53B	2.55B	3.08B	3.55B
EBITDA Margin %	0.21%	0.22%	0.22%	0.2%	0.21%	0.21%	0.2%	0.18%	0.2%	0.23%
EBITDA Growth %	-0.02%	0.01%	0.08%	-0.06%	-0.08%	-0.06%	0%	0.01%	0.21%	0.15%
D&A (Non-Cash Add-back)	859.5M	850.7M	893.3M	938.3M	775.3M	812.7M	843.1M	938.7M	923.6M	935.4M
EBIT	1.56B	1.93B	2.03B	2.08B	1.97B	1.41B	1.63B	1.61B	2.11B	2.91B
Net Interest Income+	-232.4M	-255.4M	-247.4M	-259.2M	-218.2M	-231.5M	-203.9M	-255.2M	-302.5M	-280.6M
Interest Income	10.1M	20.8M	19.6M	14.9M	23.7M	14.6M	12.3M	8.5M	52.2M	57.8M
Interest Expense	242.5M	276.2M	267M	274.1M	241.9M	246.1M	216.2M	263.7M	354.7M	338.4M
Other Income/Expense	-665.2M	-357M	-437.1M	-176.9M	-177M	-548.2M	-270.3M	-266.1M	-405.2M	-41.2M
Pretax Income+	1.32B	1.65B	1.76B	1.8B	1.73B	1.16B	1.41B	1.34B	1.76B	2.57B
Pretax Margin %	0.1%	0.13%	0.13%	0.12%	0.14%	0.1%	0.11%	0.09%	0.11%	0.16%
Income Tax+	300.5M	403.3M	243.8M	364.3M	288.6M	176.6M	270.2M	234.5M	362.5M	439.3M
Effective Tax Rate %	0.76%	0.75%	0.85%	0.79%	0.9%	-1.04%	0.8%	0.81%	0.78%	0.82%
Net Income+	1B	1.23B	1.5B	1.43B	1.56B	-1.21B	1.13B	1.09B	1.37B	2.11B
Net Margin %	0.07%	0.09%	0.11%	0.1%	0.12%	-0.1%	0.09%	0.08%	0.09%	0.13%
Net Income Growth %	-0.17%	0.23%	0.22%	-0.05%	0.09%	-1.77%	1.94%	-0.03%	0.26%	0.54%
Net Income (Continuing)	1.02B	1.25B	1.52B	1.44B	1.44B	984.8M	1.14B	1.11B	1.39B	2.13B
Discontinued Operations	0	0	0	178.8M	133.3M	-2.17B	0	0	0	0
Minority Interest	70.5M	69.8M	70.2M	50.4M	40.5M	35M	28.9M	22.5M	27.5M	31.9M
EPS (Diluted)+	3.32	4.14	5.12	4.88	5.33	-4.20	3.91	3.81	4.79	7.37
EPS Growth %	-0.16%	0.25%	0.24%	-0.05%	0.09%	-1.79%	1.93%	-0.03%	0.26%	0.54%
EPS (Basic)	3.38	4.20	5.20	4.95	5.41	-4.20	3.95	3.83	4.82	7.43
Diluted Shares Outstanding	301.4M	296.7M	294M	292.8M	292.5M	287M	289.1M	286.6M	286.5M	286.6M
Basic Shares Outstanding	296.4M	292.5M	289.6M	288.6M	288.1M	287M	286.3M	285.2M	285M	284.3M
Dividend Payout Ratio	0.4%	0.35%	0.3%	0.35%	0.35%	-	0.5%	0.55%	0.45%	0.31%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	4.45B	4.28B	4.6B	4.68B	4.83B	5.12B	4.69B	5.49B	5.64B	6.03B
Cash & Short-Term Investments	92.8M	327.4M	211.4M	114.7M	118.8M	1.26B	359.9M	598.6M	919.5M	1.26B
Cash Only	92.8M	327.4M	211.4M	114.7M	118.8M	1.26B	359.9M	598.6M	919.5M	1.26B
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	2.39B	2.45B	2.57B	2.66B	2.49B	2.44B	2.63B	2.88B	3.02B	3.03B
Days Sales Outstanding	64.41	67.88	67.84	66.25	72.32	75.61	75.38	74.15	71.98	70.22
Inventory	1.39B	1.32B	1.45B	1.55B	1.08B	1.29B	1.49B	1.79B	1.5B	1.46B
Days Inventory Outstanding	70.57	70.31	65.92	65.56	56.13	68.06	72.49	74.64	59.77	60.09
Other Current Assets	481.7M	88.1M	211.5M	222M	1.04B	30.5M	84.5M	96.7M	62.4M	124.3M
Total Non-Current Assets+	14.19B	14.05B	15.37B	15.4B	16.04B	13.01B	16.52B	15.97B	16.2B	16.36B
Property, Plant & Equipment	3.23B	3.37B	3.71B	3.84B	3.69B	3.55B	3.69B	3.74B	4.03B	4.48B
Fixed Asset Turnover	4.20x	3.91x	3.73x	3.82x	3.40x	3.32x	3.46x	3.79x	3.80x	3.52x
Goodwill	6.49B	6.38B	7.17B	7.08B	5.57B	6.01B	8.06B	8.01B	8.15B	7.91B
Intangible Assets	4.11B	3.82B	4.02B	3.8B	2.93B	2.98B	4.22B	3.68B	3.49B	3.31B
Long-Term Investments	0	0	0	0	0	0	29.4M	44.5M	23.6M	45.1M
Other Non-Current Assets	307.6M	392.7M	372M	580M	3.71B	312.8M	396M	382.5M	389.8M	469.8M
Total Assets+	18.64B	18.33B	19.96B	20.07B	20.87B	18.13B	21.21B	21.46B	21.85B	22.39B
Asset Turnover	0.73x	0.72x	0.69x	0.73x	0.60x	0.65x	0.60x	0.66x	0.70x	0.70x
Asset Growth %	-0.04%	-0.02%	0.09%	0.01%	0.04%	-0.13%	0.17%	0.01%	0.02%	0.02%
Total Current Liabilities+	4.76B	3.02B	3.43B	3.69B	3.63B	2.93B	3.55B	4.21B	4.35B	4.79B
Accounts Payable	1.05B	983.2M	1.18B	1.26B	1.08B	1.16B	1.38B	1.73B	1.57B	1.81B
Days Payables Outstanding	53.36	52.39	53.66	53.23	55.8	61.46	67.26	71.95	62.53	74.24
Short-Term Debt	2.21B	541.3M	564.4M	743.6M	380.6M	17.3M	411M	505.1M	630.4M	615.7M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	948.3M	562.4M	1B	930.3M	1.56B	982.9M	937.4M	1.18B	1.1B	1.58B
Current Ratio	0.93x	1.42x	1.34x	1.27x	1.33x	1.75x	1.32x	1.30x	1.30x	1.26x
Quick Ratio	0.64x	0.98x	0.92x	0.85x	1.03x	1.31x	0.90x	0.88x	0.95x	0.95x
Cash Conversion Cycle	81.62	85.8	80.09	78.58	72.65	82.21	80.61	76.84	69.22	56.06
Total Non-Current Liabilities+	6.9B	8.34B	8.83B	8.34B	8.51B	8.99B	10.4B	10B	9.43B	8.81B
Long-Term Debt	4.26B	6.15B	6.76B	6.3B	5.97B	6.67B	8.35B	8.08B	7.55B	6.95B
Capital Lease Obligations	0	0	0	6.2M	346M	300.5M	282.6M	337.8M	425.5M	575.5M
Deferred Tax Liabilities	1.28B	970.2M	635.4M	764.6M	537.3M	483.9M	622M	505.6M	418.2M	280M
Other Non-Current Liabilities	1.36B	1.22B	2.08B	1.26B	1.66B	1.54B	1.15B	1.08B	1.03B	1B
Total Liabilities	11.66B	11.36B	12.27B	12.02B	12.14B	11.92B	13.95B	14.21B	13.77B	13.6B
Total Debt+	6.47B	6.69B	7.32B	7.05B	6.82B	7.11B	9.16B	9.03B	8.73B	8.28B
Net Debt	6.37B	6.36B	7.11B	6.93B	6.7B	5.85B	8.8B	8.43B	7.81B	7.03B
Debt / Equity	0.93x	0.96x	0.95x	0.87x	0.78x	1.15x	1.26x	1.24x	1.08x	0.94x
Debt / EBITDA	2.27x	2.34x	2.37x	2.41x	2.54x	2.82x	3.62x	3.54x	2.83x	2.33x
Net Debt / EBITDA	2.24x	2.23x	2.30x	2.37x	2.50x	2.32x	3.48x	3.31x	2.53x	1.98x
Interest Coverage	8.18x	7.27x	8.24x	7.23x	7.89x	6.95x	7.79x	6.10x	6.09x	7.72x
Total Equity+	6.98B	6.97B	7.69B	8.05B	8.73B	6.2B	7.25B	7.26B	8.07B	8.79B
Equity Growth %	-0.05%	-0%	0.1%	0.05%	0.08%	-0.29%	0.17%	0%	0.11%	0.09%
Book Value per Share	23.16	23.49	26.15	27.51	29.83	21.61	25.09	25.33	28.18	30.67
Total Shareholders' Equity	6.91B	6.9B	7.62B	8B	8.69B	6.17B	7.22B	7.24B	8.04B	8.76B
Common Stock	350.3M	352.6M	354.7M	357M	359.6M	362.6M	364.1M	364.7M	365.7M	367.8M
Retained Earnings	6.16B	6.97B	8.05B	8.91B	9.99B	8.24B	8.81B	9.32B	10.08B	11.52B
Treasury Stock	-3.26B	-3.98B	-4.58B	-5.13B	-5.49B	-6.68B	-6.78B	-7.3B	-7.31B	-8.31B
Accumulated OCI	-1.42B	-1.71B	-1.64B	-1.76B	-2.09B	-1.99B	-1.63B	-1.73B	-1.85B	-1.98B
Minority Interest	70.5M	69.8M	70.2M	50.4M	40.5M	35M	28.9M	22.5M	27.5M	31.9M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	2B	1.94B	2.09B	2.28B	2.42B	1.86B	2.06B	1.79B	2.41B	2.81B
Operating CF Margin %	0.15%	0.15%	0.15%	0.16%	0.19%	0.16%	0.16%	0.13%	0.16%	0.18%
Operating CF Growth %	0.1%	-0.03%	0.08%	0.09%	0.06%	-0.23%	0.11%	-0.13%	0.35%	0.17%
Net Income	1.02B	1.25B	1.52B	1.44B	1.44B	-1.19B	1.14B	1.11B	1.37B	2.13B
Depreciation & Amortization	859.5M	850.7M	893.3M	938.3M	775.3M	812.7M	843.1M	938.7M	923.6M	935.4M
Stock-Based Compensation	78.2M	85.7M	90.5M	94.4M	84M	82.1M	89.5M	87.8M	95.1M	134.8M
Deferred Taxes	-244.5M	-90.6M	-354.5M	85.1M	-22.1M	-45.8M	-1.1M	-142.6M	-55.7M	-190.5M
Other Non-Cash Items	368.8M	-182.2M	-100.1M	39.4M	258.1M	2.41B	-14.2M	72.3M	-86.2M	-373.8M
Working Capital Changes	-79.4M	29M	39.7M	-319.8M	-117.5M	-209.2M	600K	-276.7M	162.7M	176.1M
Change in Receivables	-24M	900K	-91.8M	-164.1M	-173.1M	155.6M	-178.2M	-319.6M	-84.3M	-146.7M
Change in Inventory	-48.6M	18.8M	-85.5M	-141.1M	22.3M	-179.5M	-73M	-402.9M	320.3M	-115.6M
Change in Payables	-46.1M	-55.1M	121.1M	113.5M	22.9M	55.9M	200.4M	394.7M	-232.3M	300M
Cash from Investing+	-915.8M	-829.5M	-1.67B	-1.03B	-1.2B	-414.5M	-4.58B	-716.8M	-990.5M	-433.8M
Capital Expenditures	-815.2M	-756.8M	-868.6M	-847.1M	-731.3M	-489M	-643M	-712.8M	-774.8M	-994.5M
CapEx % of Revenue	0.06%	0.06%	0.06%	0.06%	0.06%	0.04%	0.05%	0.05%	0.05%	0.06%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	45.6M	-55.9M	53M	-6.4M	-83.2M	445.3M	-13M	3.2M	-35.3M	-16.1M
Cash from Financing+	-1.15B	-868.2M	-522.7M	-1.17B	-1.35B	-341.8M	1.6B	-837.3M	-1.05B	-2.02B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-400.7M	-427.5M	-448.7M	-496.5M	-552.9M	-560.8M	-566.4M	-602.8M	-617.3M	-664.3M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	128M	84.9M	59.6M	94.3M	209.6M	221.9M	154.9M	194M	78.2M	255.2M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	1.18B	1.18B	1.22B	1.43B	1.69B	1.37B	1.42B	1.08B	1.64B	1.82B
FCF Margin %	0.09%	0.09%	0.09%	0.1%	0.13%	0.12%	0.11%	0.08%	0.11%	0.12%
FCF Growth %	0.16%	-0%	0.03%	0.17%	0.18%	-0.19%	0.03%	-0.24%	0.52%	0.11%
FCF per Share	3.93	3.99	4.16	4.89	5.78	4.78	4.91	3.75	5.71	6.35
FCF Conversion (FCF/Net Income)	2.00x	1.58x	1.39x	1.59x	1.55x	-1.54x	1.82x	1.64x	1.76x	1.33x
Interest Paid	237.2M	267M	239.3M	206.4M	189.4M	0	208.7M	222.4M	324.8M	342.6M
Taxes Paid	533.1M	359.1M	402.8M	365.1M	337.4M	366.9M	275.7M	308.9M	469.2M	647.4M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	13.95%	17.63%	20.53%	18.16%	18.58%	-16.15%	16.8%	15.05%	17.9%	25.06%
Return on Invested Capital (ROIC)	10.99%	11.28%	11.73%	9.98%	9.41%	9.33%	8.99%	7.61%	10.27%	12.36%
Gross Margin	46.99%	47.92%	42.13%	41.31%	44.01%	41.54%	41.01%	38.2%	40.32%	43.47%
Net Margin	7.4%	9.35%	10.87%	9.74%	12.41%	-10.22%	8.87%	7.69%	8.96%	13.42%
Debt / Equity	0.93x	0.96x	0.95x	0.87x	0.78x	1.15x	1.26x	1.24x	1.08x	0.94x
Interest Coverage	8.18x	7.27x	8.24x	7.23x	7.89x	6.95x	7.79x	6.10x	6.09x	7.72x
FCF Conversion	2.00x	1.58x	1.39x	1.59x	1.55x	-1.54x	1.82x	1.64x	1.76x	1.33x
Revenue Growth	-5.15%	-2.9%	5.19%	6.02%	-14.36%	-6.14%	8%	11.42%	7.98%	2.75%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Global Industrial	4.86B	4.62B	4.88B	5.46B	5.57B	5.96B	6.3B	6.74B	7.19B	7.86B
Global Industrial Growth	-	-4.95%	5.66%	11.97%	1.97%	7.00%	5.79%	6.84%	6.78%	9.23%
Global Institutional and Specialty	-	-	-	-	-	-	3.98B	4.48B	5B	5.41B
Global Institutional and Specialty Growth	-	-	-	-	-	-	-	12.61%	11.59%	8.30%
Global Healthcare and Life Sciences	-	-	-	-	-	-	1.2B	1.57B	1.58B	1.43B
Global Healthcare and Life Sciences Growth	-	-	-	-	-	-	-	31.34%	0.44%	-9.06%
Global Pest Elimination	-	-	-	-	-	-	-	-	-	1.17B
Global Pest Elimination Growth	-	-	-	-	-	-	-	-	-	-
Other	773.4M	806.5M	823.5M	877.6M	907.5M	1.09B	1.23B	1.35B	1.44B	-
Other Growth	-	4.28%	2.11%	6.57%	3.41%	20.47%	12.22%	10.44%	6.58%	-
Global Institutional	4.39B	4.5B	4.74B	5.2B	5.24B	3.58B	-	-	-	-
Global Institutional Growth	-	2.33%	5.55%	9.69%	0.60%	-31.67%	-	-	-	-
Global Energy	3.83B	3.04B	3.2B	3.5B	3.33B	-	-	-	-	-
Global Energy Growth	-	-20.65%	5.39%	9.46%	-4.79%	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	-	-	-	7.42B	8.12B	8.31B
UNITED STATES Growth	-	-	-	-	-	-	-	-	9.32%	2.34%
Europe	-	-	-	-	-	-	-	2.96B	3.22B	3.19B
Europe Growth	-	-	-	-	-	-	-	-	8.76%	-0.78%
Asia Pacific	-	-	-	-	-	-	-	1.21B	1.3B	1.34B
Asia Pacific Growth	-	-	-	-	-	-	-	-	6.97%	3.54%
Latin America	-	-	-	-	-	-	-	860.6M	1.01B	1.1B
Latin America Growth	-	-	-	-	-	-	-	-	17.85%	8.45%
C [N]	-	-	-	-	-	-	-	683.6M	670.3M	696.9M
C [N] Growth	-	-	-	-	-	-	-	-	-1.95%	3.97%
Middle East And Africa	-	-	-	-	-	-	-	509.3M	552.9M	625.2M
Middle East And Africa Growth	-	-	-	-	-	-	-	-	8.56%	13.08%
Canada	-	-	-	-	-	-	-	416.2M	453.1M	478.7M
Canada Growth	-	-	-	-	-	-	-	-	8.87%	5.65%

Frequently Asked Questions

Valuation & Price

Ecolab Inc. (ECL) has a price-to-earnings (P/E) ratio of 37.7x. This suggests investors expect higher future growth.

Growth & Financials

Ecolab Inc. (ECL) reported $15.89B in revenue for fiscal year 2024. This represents a 133% increase from $6.83B in 2011.

Ecolab Inc. (ECL) grew revenue by 2.7% over the past year. Growth has been modest.

Yes, Ecolab Inc. (ECL) is profitable, generating $1.98B in net income for fiscal year 2024 (13.4% net margin).

Dividend & Returns

Yes, Ecolab Inc. (ECL) pays a dividend with a yield of 0.83%. This makes it attractive for income-focused investors.

Ecolab Inc. (ECL) has a return on equity (ROE) of 25.1%. This is excellent, indicating efficient use of shareholder capital.

Ecolab Inc. (ECL) generated $1.55B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...